National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19

被引：2

作者：

Mirenayat, Maryam Sadat ^{[1
]}

Abedini, Atefeh ^{[1
]}

Kiani, Arda ^{[2
]}

Eslaminejad, Alireza ^{[2
]}

Adiminaghan, Parisa ^{[3
]}

Malekmohammad, Majid ^{[2
]}

Heshmatnia, Jalal ^{[4
]}

Nadji, Seyed Alireza ^{[5
]}

Idani, Esmaeil ^{[1
]}

Zahiri, Reyhaneh ^{[1
]}

Lookzadeh, Somayeh ^{[1
]}

Sheikhzade, Hakimeh ^{[4
]}

Dastan, Farzaneh ^{[1
]}

Toutkaboni, Mihan Porabdollah ^{[1
]}

Rezaei, Mitra Sadat ^{[5
]}

Askari, Elham ^{[1
]}

Tabarsi, Payam ^{[4
]}

Marjani, Majid ^{[4
]}

Moniri, Afshin ^{[4
]}

Hashemian, Seyed Mohammad Reza ^{[4
]}

Farzanegan, Behrooz ^{[2
]}

Abtahian, Zahra ^{[4
]}

Yassari, Fatemeh ^{[1
]}

Mansouri, Nazanin ^{[1
]}

Mansouri, Davood ^{[4
]}

Vasheghani, Maryam ^{[1
]}

Mansourafshar, Babak ^{[4
]}

Dezfoli, Mojtaba Mokhber ^{[2
]}

Soleimani, Salman ^{[2
]}

Seifi, Sharareh ^{[1
]}

Naghashzadeh, Farah ^{[6
]}

Fakharian, Atefeh ^{[1
]}

Varahram, Mohammad ^{[7
]}

Jamaati, Hamidreza ^{[1
]}

Zali, Alireza ^{[8
]}

Velayati, Ali Akbar ^{[4
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr CRDRC, Tehran, Iran

[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tracheal Dis Res Ctr, Tehran, Iran

[3] Shahid Beheshti Univ Med Sci, NRITLD, Dept Pulm & Sleep Med, Tehran, Iran

[4] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Clin TB & Epidemiol Res Ctr, Tehran, Iran

[5] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran

[6] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Lung Transplantat Res Ctr LTRC, Tehran, Iran

[7] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Mycobacteriol Res Ctr, Tehran, Iran

[8] Shahid Beheshti Univ Med Sci, Res Ctr Neurosurg & Funct Nerves, Tehran, Iran

来源：

IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2022年 / 21卷 / 01期

关键词：

Acute Respiratory Distress Syndrome (ARDS); Coronavirus Disease; Clinical Management; SARS-COV-2; Treatment Guidelines;

D O I：

10.5812/ijpr.123947

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients.

引用

页数：8

共 50 条

[31] Diagnosis and treatment protocol for COVID-19 patients (Trial Version 9)
Zhang, Zongjiu
HEALTH CARE SCIENCE, 2022, 1 (01): : 14 - 28
[32] Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre
Lorna R. Henderson
Helen McShane
Vasiliki Kiparoglou
Health Research Policy and Systems, 20
[33] Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research Centre
Henderson, Lorna R.
McShane, Helen
Kiparoglou, Vasiliki
HEALTH RESEARCH POLICY AND SYSTEMS, 2022, 20 (01)
[34] COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
Nichetti, Federico
Bini, Marta
Ambrosini, Margherita
Ottini, Arianna
Rametta, Alessandro
Leporati, Rita
Polastri, Daniela
Pircher, Chiara
Dotti, Katia
Ferrari, Laura
de Braud, Filippo
ESMO OPEN, 2020, 5 (SUPPL_3)
[35] COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study
Nichetti, F.
Bini, M.
Dotti, K. F.
Ottini, A.
Ambrosini, M.
Rametta, A.
Leporati, R.
Ferrari, L.
De Braud, F. G. M.
ANNALS OF ONCOLOGY, 2020, 31 : S1003 - S1003
[36] COVID-19: For national and European research coordination
不详
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E69 - E70
[37] COVID-19: for a national and European coordination of research
不详
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (07): : 706 - 707
[38] Current treatment protocol for COVID-19 in India
Sharma S.
Basu S.
Shetti N.P.
Aminabhavi T.M.
Sensors International, 2020, 1
[39] Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
Fesu, Dorottya
Polivka, Lorinc
Barczi, Eniko
Foldesi, Marcell
Horvath, Gabor
Hidvegi, Edit
Bohacs, Aniko
Muller, Veronika
INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 565 - 571
[40] Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
Dorottya Fesu
Lorinc Polivka
Eniko Barczi
Marcell Foldesi
Gabor Horvath
Edit Hidvegi
Aniko Bohacs
Veronika Muller
Inflammopharmacology, 2023, 31 : 565 - 571

← 1 2 3 4 5 →